XML 23 R12.htm IDEA: XBRL DOCUMENT v3.25.1
Balance Sheet Components
3 Months Ended
Mar. 31, 2025
Balance Sheet Components  
Balance Sheet Components

6. Balance Sheet Components

​

Allowance for Expected Credit Losses

​

The following is a roll-forward of the allowances for expected credit losses related to trade accounts receivable for the three months ended March 31, 2025 and 2024:

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

    

March 31, 

​

​

2025

​

2024

​

​

​

(in thousands)

Beginning balance

​

$

7,259

​

$

6,481

Provision for expected credit losses

​

​

195

​

​

929

Write-offs

​

​

(20)

​

​

(158)

Total

​

$

7,434

​

$

7,252

​

Property and Equipment, net

​

The Company’s property and equipment consists of the following:

​

​

​

​

​

​

​

​

​

​

March 31, 

​

December 31, 

​

Useful Life

2025

    

2024

​

​

(in thousands)

Machinery and equipment

3-5 years

$

129,005

​

$

117,076

Computer equipment

3 years

​

3,287

​

 

3,178

Purchased and capitalized software held for internal use

3 years

​

14,587

​

​

13,178

Leasehold improvements

Lesser of useful life or lease term

​

48,883

​

 

48,569

Construction-in-process

​

​

71,271

​

 

58,461

​

​

​

267,033

​

 

240,462

Less: Accumulated depreciation and amortization

​

​

(86,580)

​

 

(78,416)

Total property and equipment, net

​

$

180,453

​

$

162,046

​

The Company’s long-lived assets are located in the United States.

Depreciation expense for the three months ended March 31, 2025 and 2024 was $8.2 million and $6.3 million, respectively. The Company did not incur any impairment charges during either period.

Other Accrued Liabilities

​

The Company’s other accrued liabilities consisted of the following:

​

​

​

​

​

​

​

​

​

March 31, 

    

December 31, 

 

​

2025

    

2024

 

​

(in thousands)

 

Reserves for refunds to insurance carriers

$

10,171

​

$

11,276

​

Accrued charges for third-party testing

​

16,963

​

​

12,321

​

Testing and laboratory materials from suppliers

​

10,754

​

​

7,893

​

Marketing and corporate affairs

​

17,898

​

​

16,548

​

Legal, audit and consulting fees

​

66,097

​

 

54,208

​

Accrued shipping charges

​

1,945

​

​

1,625

​

Sales and income tax payable

​

5,602

​

​

4,416

​

Accrued third-party service fees

​

8,812

​

​

9,046

​

Clinical trials and studies

 

10,788

​

​

10,097

​

Operating lease liabilities, current portion

​

12,199

​

​

10,168

​

Property and equipment purchases

​

9,525

​

​

7,098

​

Other accrued expenses

 

7,695

​

​

2,197

​

Total other accrued liabilities

$

178,449

​

$

146,893

​

​

Reserves for refunds to insurance carriers include overpayments from and amounts to be refunded to insurance carriers, and additional amounts that the Company estimates for potential refund requests during the period. When and if these previously accrued amounts are no longer required based on actual refunds requested, any remaining reserve amounts are released. When the Company releases these previously accrued amounts, they are recognized as product revenues in the statements of operations and comprehensive loss.

​

The following table summarizes the reserve balance and activities for refunds to insurance carriers for the three months ending March 31, 2025 and 2024:

​

​

​

​

​

​

​

​

​

March 31, 

​

​

2025

    

2024

​

​

(in thousands)

​

Beginning balance

$

11,276

​

$

23,245

​

Additional (reversals) reserves

 

(622)

​

 

227

​

Refunds to carriers

 

—

​

​

(3,095)

​

Reserves released to revenue

​

(483)

​

​

(2,354)

​

Ending balance

$

10,171

​

$

18,023

​

​

​

​

​

​

​

​

​